The Medical Treatment of Inflammatory Breast Cancer
- 29 February 2008
- journal article
- research article
- Published by Elsevier BV in Seminars in Oncology
- Vol. 35 (1), 64-71
- https://doi.org/10.1053/j.seminoncol.2007.11.012
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Disease-free and overall survival after pathologic complete disease remission of cytologically proven inflammatory breast carcinoma axillary lymph node metastases after primary systemic chemotherapyCancer, 2006
- Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profilingBreast Cancer Research and Treatment, 2005
- Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast CancerNew England Journal of Medicine, 2005
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005
- Increased Angiogenesis and Lymphangiogenesis in Inflammatory versus Noninflammatory Breast Cancer by Real-Time Reverse Transcriptase-PCR Gene Expression QuantificationClinical Cancer Research, 2004
- p53 Expression as a Prognostic Marker in Inflammatory Breast CancerClinical Cancer Research, 2004
- Prognostic Indicators and Survival in Patients With Stage IIIB Inflammatory Breast Carcinoma After Dose-Intense ChemotherapyJournal of Clinical Oncology, 2004
- Prognosis of dermal lymphatic invasion with or without clinical signs of inflammatory breast cancerInternational Journal of Cancer, 2003
- Increased incidence of ERBB2 overexpression and TP53 mutation in inflammatory breast cancerOncogene, 2002
- Inflammatory cancer of the breast: Analysis of 114 casesJournal of Surgical Oncology, 1981